New eye drops aim to halt blinding eye disease before It's too late
Disease control
Recruiting now
This study tests whether daily GAL-101 eye drops can slow the growth of geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. About 110 adults aged 55 and older with early-stage damage (not yet affecting central vision) will receive eith…
Phase: PHASE2 • Sponsor: Galimedix Therapeutics Inc • Aim: Disease control
Last updated May 04, 2026 16:30 UTC